Njord Medtech has been selected as one of the finalist winners of Business Challenge 2022.
With almost 400 companies applying to this year's competition, Njord was first selected among the top 12 companies for the pitch competition at Tändstickspalatset in Stockholm, Sweden.
After the first round of company presentations, Njord was further selected as one of the final six companies to present to the complete Business Challenge jury and present network of around 80 Swedish-based business leaders and investors.
This implies that Njord Medtech will be one of the companies receiving continued mentoring and business development support from the program during 2022/2023. The program is co-sponsored by prominent actors such as Investor, FAM, NASDAQ, SEB, and Vinge among others.
“We are very happy with Njord receiving this type of recognition. A true privilege being selected by the eminent jury members and be given the opportunity to improve our business with an experienced set of leaders and investors in the coming half-year”, commented CEO Jacob Ahrnstein.